Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$2.88 - $8.8 $529,666 - $1.62 Million
183,912 Added 45.59%
587,297 $1.98 Million
Q2 2023

Aug 09, 2023

BUY
$7.46 - $10.67 $461,572 - $660,184
61,873 Added 18.12%
403,385 $3.34 Million
Q1 2023

May 11, 2023

SELL
$8.44 - $13.35 $411,028 - $650,145
-48,700 Reduced 12.48%
341,512 $2.98 Million
Q4 2022

Feb 09, 2023

BUY
$5.58 - $13.94 $434,704 - $1.09 Million
77,904 Added 24.94%
390,212 $4.76 Million
Q3 2022

Nov 10, 2022

BUY
$6.1 - $11.41 $1.72 Million - $3.22 Million
282,113 Added 934.3%
312,308 $1.98 Million
Q2 2022

Aug 10, 2022

BUY
$6.61 - $11.99 $199,588 - $362,038
30,195 New
30,195 $271,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $290M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.